Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLECT-1: Rosiglitazone Monotherapy in Alzheimer's
NCT00428090Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of rosiglitazone in Alzheimer's disease (AD), sponsored by GSK. Started Feb 2007; status: completed.
02
Drugs
rosiglitazone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00428090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428090.